- Home
- MVO vs INO Comparison
MVO vs INO Comparison
Compare MVO & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVO
- INO
- Stock Information
- Founded
- MVO 2006
- INO 1979
- Country
- MVO United States
- INO United States
- Employees
- MVO N/A
- INO N/A
- Industry
- MVO Oil & Gas Production
- INO Medical/Dental Instruments
- Sector
- MVO Energy
- INO Health Care
- Exchange
- MVO Nasdaq
- INO Nasdaq
- Market Cap
- MVO 65.0M
- INO 69.3M
- IPO Year
- MVO N/A
- INO 1998
- Fundamental
- Price
- MVO $5.83
- INO $1.86
- Analyst Decision
- MVO
- INO Buy
- Analyst Count
- MVO 0
- INO 5
- Target Price
- MVO N/A
- INO $8.80
- AVG Volume (30 Days)
- MVO 55.1K
- INO 1.8M
- Earning Date
- MVO 01-01-0001
- INO 08-12-2025
- Dividend Yield
- MVO 17.46%
- INO N/A
- EPS Growth
- MVO N/A
- INO N/A
- EPS
- MVO 1.46
- INO N/A
- Revenue
- MVO N/A
- INO $182,337.00
- Revenue This Year
- MVO N/A
- INO N/A
- Revenue Next Year
- MVO N/A
- INO $20,588.06
- P/E Ratio
- MVO $7.29
- INO N/A
- Revenue Growth
- MVO N/A
- INO N/A
- 52 Week Low
- MVO $8.85
- INO $1.30
- 52 Week High
- MVO $13.95
- INO $8.13
- Technical
- Relative Strength Index (RSI)
- MVO 54.04
- INO 66.43
- Support Level
- MVO $5.55
- INO $1.40
- Resistance Level
- MVO $5.73
- INO $1.73
- Average True Range (ATR)
- MVO 0.13
- INO 0.10
- MACD
- MVO 0.01
- INO 0.05
- Stochastic Oscillator
- MVO 87.50
- INO 69.93
About MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These properties include producing oil and gas wells.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.